Waning of antibody levels induced by a 13-valent pneumococcal conjugate vaccine, using a 3 + 0 schedule, within the first year of life among children younger than 5 years in Blantyre, Malawi

Waning of antibody levels induced by a 13-valent pneumococcal

Pneumococcal conjugate vaccination schedules in infants

High residual carriage of vaccine-serotype Streptococcus

Vaccines, Free Full-Text

Estimated impact of revising the 13-valent pneumococcal conjugate

Streptococcus pneumoniae and other bacterial nasopharyngeal

Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Clinical

Adapted SPIRIT figure showing the timeline of cluster allocation

Vaccines, Free Full-Text

Salivary antibody responses to ten-valent pneumococcal conjugate